THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 23 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,294,000 | +112.1% | 1,318,000 | +100.0% | 0.00% | – |
| Q3 2021 | $610,000 | -3.2% | 659,000 | 0.0% | 0.00% | – |
| Q2 2021 | $630,000 | -49.9% | 659,000 | -46.4% | 0.00% | -100.0% |
| Q1 2021 | $1,257,000 | -34.2% | 1,229,000 | -39.0% | 0.00% | 0.0% |
| Q4 2020 | $1,910,000 | +40.1% | 2,016,000 | +33.0% | 0.00% | 0.0% |
| Q3 2020 | $1,363,000 | -75.6% | 1,516,000 | -73.8% | 0.00% | -75.0% |
| Q1 2020 | $5,586,000 | +62.3% | 5,788,000 | +74.0% | 0.00% | +100.0% |
| Q4 2019 | $3,442,000 | +15.5% | 3,326,000 | +3.1% | 0.00% | 0.0% |
| Q3 2019 | $2,979,000 | +27.9% | 3,226,000 | +20.1% | 0.00% | +100.0% |
| Q2 2019 | $2,330,000 | +24.7% | 2,686,000 | +39.2% | 0.00% | 0.0% |
| Q1 2019 | $1,869,000 | – | 1,930,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 6,000,000 | $5,827,000 | 3.55% |
| DeepCurrents Investment Group LLC | 21,223,000 | $20,803,000 | 1.80% |
| ZAZOVE ASSOCIATES LLC | 19,230,000 | $18,725,000 | 1.77% |
| Mohican Financial Management, LLC | 500,000 | $494,000 | 1.61% |
| Castle Creek Arbitrage, LLC | 5,149,000 | $5,015,000 | 1.47% |
| LINDEN ADVISORS LP | 62,688,000 | $61,071,000 | 1.40% |
| Verition Fund Management LLC | 10,817,000 | $10,504,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,100,000 | $23,451,000 | 0.32% |
| Baupost Group | 30,000,000 | $29,213,000 | 0.24% |
| SSI INVESTMENT MANAGEMENT LLC | 2,763,000 | $2,676,000 | 0.22% |